What is Crinetics Pharmaceuticals's total revenue?

Crinetics Pharmaceuticals (CRNX) reported total revenue of $10.73M in Q1 2026.

How has Crinetics Pharmaceuticals's total revenue changed year-over-year?

Crinetics Pharmaceuticals's total revenue increased by 2873.4% year-over-year, from $361K to $10.73M.

What is the long-term trend for Crinetics Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's total revenue has grown at a 63.5% compound annual growth rate (CAGR), from $1.08M to $7.7M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Crinetics Pharmaceuticals CRNX Total Revenue

Total Revenue at other companies

Neurocrine BiosciencesNBIX

$814.5M+42.2%

Corcept TherapeuticsCORT

$164.9M+4.9%

Catalyst PharmaceuticalCPRX

$149.39M+5.6%

Amneal Pharmaceuticals, Inc.AMRX

$722.52M+3.9%

United TherapeuticsUTHR

$781.5M-1.6%

Rhythm Pharmaceuticals, Inc.RYTM

$60.11M+83.8%

Segments

By segment

See full

Reportable Segment$10.73M+2,873%

By product

See full

Collaboration and license revenue$428K+18.6%

Other financials

Income statement

See full

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.78B+21.9%

Enterprise value$3.71B+21.5%

P/S209.3×-3,875×

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's total revenue?: Crinetics Pharmaceuticals (CRNX) reported total revenue of $10.73M in Q1 2026.
How has Crinetics Pharmaceuticals's total revenue changed year-over-year?: Crinetics Pharmaceuticals's total revenue increased by 2873.4% year-over-year, from $361K to $10.73M.
What is the long-term trend for Crinetics Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's total revenue has grown at a 63.5% compound annual growth rate (CAGR), from $1.08M to $7.7M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.